American Registry of Pathology Expert Opinions: Immunohistochemical evaluation of classic Hodgkin lymphoma

Dennis P. O’Malley(Ambry Genetics (United States)), Mohamed E. Salama(The University of Texas at San Antonio Health Science Center), L. Jeffrey Medeiros(Delaware Division of Libraries), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Yuri Fedoriw(University of North Carolina at Chapel Hill), Chi Young Ok(The University of Texas MD Anderson Cancer Center)
Annals of Diagnostic Pathology
February 10, 2019
10.1016/j.anndiagpath.2019.02.001
Cited by 55

Related Papers

The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
|Proceedings of the National Academy of Sciences|2012|990
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|683
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Spectrum of Epithelial Neoplasms in End-Stage Renal Disease
|The American Journal of Surgical Pathology|2006|484